CureVac shares soar 13% on tie-up with Bayer over Covid-19 vaccine

95-year-old Dublin woman, Maura Byrne, who lost her husband to coronavirus, has become the first nursing home resident in the country to receive Pfizer/BioNTech's Covid-19 vaccination. Photo: Anthony Edwards

CureVac, which is a further vaccine under development in Germany, has signed up with drugs giant Bayer as a partner for its experimental shot.

The move underscores Germany’s push for a home-grown vaccine after local rival BioNTech partnered with US drugmaker Pfizer on its Covid-19 inoculation, which is already being rolled out.